Income Statement Indivior Pharmaceuticals, Inc. London S.E.

Equities

INDV

US45579U1097

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:04 2025-07-24 EDT			5-day change	1st Jan Change
1,238.00 ^GBX	+1.56%		-.--%	-

01-26	Indivior Pharmaceuticals Completes Redomiciliation to US From UK	MT
01-08	Indivior PLC Provides Earnings Guidance for the Full Year 2026	CI

a46ab80103ec1510afe8bf684272c2c.3s4Q-sXs7IiI-r46aDr0xXRt_LDHo2vZok7xgH_im_E.j4l1lJGtttK5locMBli6khgujuW35UaQ7Tm3yxSG4tyUgUa-9rWq58S_1Q

Published financial data: INDIVIOR PHARMACEUTICALS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	647M	791M	901M	1.09B	1.19B
Total Revenues	647M	791M	901M	1.09B	1.19B
Cost of Goods Sold, Total	92M	127M	159M	186M	190M
Gross Profit	555M	664M	742M	907M	998M
Selling General & Admin Expenses, Total	427M	425M	461M	543M	606M
R&D Expenses	40M	52M	72M	106M	107M
Other Operating Expenses	-	-	-3M	-2M	-5M
Other Operating Expenses, Total	467M	477M	530M	647M	708M
Operating Income	88M	187M	212M	260M	290M
Interest Expense, Total	-17M	-18M	-22M	-30M	-41M
Interest And Investment Income	7M	1M	18M	43M	23M
Net Interest Expenses	-10M	-17M	-4M	13M	-18M
Other Non Operating Income (Expenses)	0	3M	1M	-1M	-1M
EBT, Excl. Unusual Items	78M	173M	209M	272M	271M
Restructuring Charges	-11M	1M	-	-	-53M
Gain (Loss) On Sale Of Investments	-	-	-	-	-9M
Gain (Loss) On Sale Of Assets	-	20M	-	-	-
Asset Writedown	-	-	-	-	-
In Process R&D Expenses	-	-	-	-	-1M
Insurance Settlements	-	12M	5M	1M	-
Legal Settlements	-235M	-14M	-303M	-247M	-195M
Other Unusual Items	-5M	-2M	-6M	-25M	-
EBT, Incl. Unusual Items	-173M	190M	-95M	1M	13M
Income Tax Expense	-25M	-15M	-42M	-1M	11M
Earnings From Continuing Operations	-148M	205M	-53M	2M	2M
Net Income to Company	-148M	205M	-53M	2M	2M
Net Income - (IS)	-148M	205M	-53M	2M	2M
Net Income to Common Incl Extra Items	-148M	205M	-53M	2M	2M
Net Income to Common Excl. Extra Items	-148M	205M	-53M	2M	2M
Per Share Items
Net EPS - Basic	-1.01	1.41	-0.38	0.01	0.02
Basic EPS - Continuing Operations	-1.01	1.41	-0.38	0.01	0.02
Basic Weighted Average Shares Outstanding	147M	146M	139M	137M	132M
Net EPS - Diluted	-1.01	1.35	-0.38	0.01	0.02
Diluted EPS - Continuing Operations	-1.01	1.35	-0.38	0.01	0.02
Diluted Weighted Average Shares Outstanding	147M	154M	139M	142M	133M
Normalized Basic EPS	0.33	0.74	0.94	1.24	1.28
Normalized Diluted EPS	0.33	0.7	0.94	1.2	1.27
Dividend Per Share	-	-	-	-	-
Payout Ratio	-	-	-	-	-
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	101M	199M	223M	269M	316M
EBITA	94M	193M	217M	262M	290M
EBIT	88M	187M	212M	260M	290M
EBITDAR	-	-	-	-	328M
Effective Tax Rate - (Ratio)	14.45	-7.89	44.21	-100	84.62
Current Domestic Taxes	-	-	-	-	-6M
Current Foreign Taxes	-	-	-	-	11M
Total Current Taxes	8M	3M	64M	55M	5M
Deferred Domestic Taxes	-	-	-	-	25M
Deferred Foreign Taxes	-	-	-	-	-19M
Total Deferred Taxes	-33M	-18M	-106M	-56M	6M
Normalized Net Income	48.75M	108M	131M	170M	169M
Interest Capitalized	-	-	-	-	3M
Interest on Long-Term Debt	3M	2M	2M	3M	35M
Non-Cash Pension Expense	1M	-	-	-	-
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	68M
Selling and Marketing Expenses	-	-	-	-	68M
Research And Development Expense From Footnotes	40M	52M	72M	106M	108M
Net Rental Expense, Total	-	-	-	-	12M
Imputed Operating Lease Interest Expense	-	-	-	-	12.84M
Imputed Operating Lease Depreciation	-	-	-	-	-839K
Stock-Based Comp., Other (Total)	8M	11M	16M	22M	24M
Total Stock-Based Compensation	8M	11M	16M	22M	24M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	858M	1.1B	774M	316M	319M
Short Term Investments	-	-	109M	84M	1M
Trading Asset Securities, Total	-	-	10M	10M	-
Total Cash And Short Term Investments	858M	1.1B	893M	410M	320M
Accounts Receivable, Total	179M	202M	220M	254M	254M
Other Receivables	7M	13M	5M	-	34M
Total Receivables	186M	215M	225M	254M	288M
Inventory	93M	95M	114M	142M	178M
Prepaid Expenses	17M	18M	14M	23M	53M
Other Current Assets, Total	33M	14M	13M	434M	-
Total Current Assets	1.19B	1.44B	1.26B	1.26B	839M
Gross Property Plant And Equipment	171M	169M	162M	198M	229M
Accumulated Depreciation	-68M	-74M	-77M	-81M	-90M
Net Property Plant And Equipment	103M	95M	85M	117M	139M
Long-term Investments	-	-	98M	41M	27M
Goodwill	-	-	-	5M	-
Other Intangibles, Total	62M	82M	70M	232M	6M
Deferred Tax Assets Long-Term	75M	105M	219M	268M	280M
Other Long-Term Assets, Total	104M	106M	38M	28M	28M
Total Assets	1.53B	1.83B	1.77B	1.95B	1.32B
Liabilities
Accounts Payable, Total	20M	137M	36M	39M	62M
Accrued Expenses, Total	108M	147M	581M	704M	732M
Current Portion of Long-Term Debt	4M	3M	3M	3M	18M
Current Portion of Leases	8M	8M	8M	9M	10M
Current Income Taxes Payable	15M	7M	9M	18M	7M
Other Current Liabilities	444M	502M	382M	532M	110M
Total Current Liabilities	599M	804M	1.02B	1.3B	939M
Long-Term Debt	230M	239M	237M	236M	315M
Long-Term Leases	43M	36M	29M	34M	32M
Pension & Other Post Retirement Benefits	4M	3M	-	-	-
Other Non Current Liabilities	573M	547M	433M	379M	381M
Total Liabilities	1.45B	1.63B	1.72B	1.95B	1.67B
Common Stock, Total	73M	70M	68M	68M	62M
Additional Paid In Capital	6M	7M	8M	11M	90M
Retained Earnings	1.31B	1.44B	1.3B	1.24B	-454M
Comprehensive Income and Other	-1.31B	-1.31B	-1.33B	-1.32B	-46M
Total Common Equity	82M	203M	51M	0	-348M
Total Equity	82M	203M	51M	0	-348M
Total Liabilities And Equity	1.53B	1.83B	1.77B	1.95B	1.32B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	147M	140M	136M	136M	125M
ECS Total Common Shares Outstanding	147M	140M	136M	137M	125M
Book Value / Share	0.56	1.44	0.37	0	-2.78
Tangible Book Value	20M	121M	-19M	-237M	-354M
Tangible Book Value Per Share	0.14	0.86	-0.14	-1.74	-2.83
Total Debt	285M	286M	277M	282M	375M
Net Debt	-573M	-816M	-616M	-128M	55M
Debt Equivalent Oper. Leases	-	-	-	-	96M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	38M	34M	27M	38M	33M
Inventories - Work In Process, Total	19M	28M	42M	34M	51M
Inventories - Finished Goods, Total	36M	33M	45M	70M	94M
Land - (BS)	55M	55M	51M	69M	76M
Machinery, Total	73M	77M	80M	96M	76M
Full Time Employees	788	885	928	1.16K	1.03K
Part Time Employees	-	-	-	-	21
Accumulated Allowance for Doubtful Accounts (Supple)	2M	3M	2M	2M	3M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-148M	205M	-53M	2M	2M
Depreciation & Amortization - CF	15M	13M	14M	16M	26M
Amortization of Goodwill and Intangible Assets - (CF)	6M	6M	5M	2M	-
Depreciation & Amortization, Total	21M	19M	19M	18M	26M
Amortization of Deferred Charges, Total - (CF)	5M	3M	2M	10M	3M
(Gain) Loss From Sale Of Asset	-2M	-20M	-1M	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	9M
Asset Writedown & Restructuring Costs	-	-	-	-	8M
Stock-Based Compensation (CF)	8M	11M	16M	22M	24M
Other Operating Activities, Total	-58M	-38M	-112M	-62M	5M
Change In Accounts Receivable	15M	-25M	-21M	-33M	-1M
Change In Inventories	-16M	-3M	-25M	-21M	-45M
Change In Accounts Payable	-103M	201M	-98M	115M	-
Change in Other Net Operating Assets	85M	0	269M	-366M	5M
Cash from Operations	-193M	353M	-4M	-315M	36M
Capital Expenditure	-4M	-4M	-5M	-8M	-29M
Cash Acquisitions	-	-	-	-129M	-
Sale (Purchase) of Intangible assets	-	-10M	0	-45M	-2M
Investment in Marketable and Equity Securities, Total	-	-	-218M	84M	100M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-4M	-14M	-223M	-98M	69M
Long-Term Debt Issued, Total	-	250M	-	-	332M
Total Debt Issued	-	250M	-	-	332M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-11M	-244M	-12M	-20M	-240M
Total Debt Repaid	-11M	-244M	-12M	-20M	-240M
Issuance of Common Stock	1M	1M	2M	4M	3M
Repurchase of Common Stock	-	-101M	-90M	-33M	-195M
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-	-	-	3M	-2M
Cash from Financing	-10M	-94M	-100M	-46M	-102M
Foreign Exchange Rate Adjustments	5M	-1M	-1M	1M	-
Net Change in Cash	-202M	244M	-328M	-458M	3M
Supplemental Items
Cash Interest Paid	20M	18M	24M	32M	-
Cash Income Tax Paid (Refund)	34M	17M	57M	33M	-
Levered Free Cash Flow	-101M	318M	342M	-61.25M	148M
Unlevered Free Cash Flow	-90M	329M	356M	-42.5M	173M
Change In Net Working Capital	175M	-193M	-191M	202M	30M
Net Debt Issued / Repaid	-11M	6M	-12M	-20M	92M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.46	6.95	7.36	8.73	11.77
Return on Total Capital	12.66	27.31	32.44	53.28	304.62
Return On Equity %	-101.72	143.86	-41.73	7.84	-0.74
Return on Common Equity	-101.72	143.86	-41.73	7.84	-0.74
Margin Analysis
Gross Profit Margin %	85.78	83.94	82.35	82.98	84.01
SG&A Margin	66	53.73	51.17	49.68	51.01
EBITDA Margin %	15.61	25.16	24.75	24.61	26.6
EBITA Margin %	14.53	24.4	24.08	23.97	24.41
EBIT Margin %	13.6	23.64	23.53	23.79	24.41
Income From Continuing Operations Margin %	-22.87	25.92	-5.88	0.18	0.17
Net Income Margin %	-22.87	25.92	-5.88	0.18	0.17
Net Avail. For Common Margin %	-22.87	25.92	-5.88	0.18	0.17
Normalized Net Income Margin	7.53	13.67	14.5	15.55	14.26
Levered Free Cash Flow Margin	-15.55	40.15	37.93	-5.6	12.43
Unlevered Free Cash Flow Margin	-13.91	41.58	39.46	-3.89	14.58
Asset Turnover
Asset Turnover	0.41	0.47	0.5	0.59	0.77
Fixed Assets Turnover	6.16	7.99	10.01	10.82	9.03
Receivables Turnover (Average Receivables)	3.49	4.15	4.27	4.61	4.68
Inventory Turnover (Average Inventory)	1.11	1.35	1.52	1.45	1.21
Short Term Liquidity
Current Ratio	1.98	1.8	1.24	0.97	0.89
Quick Ratio	1.74	1.64	1.1	0.51	0.65
Operating Cash Flow to Current Liabilities	-0.32	0.44	-0	-0.24	0.04
Days Sales Outstanding (Average Receivables)	104.93	87.9	85.48	79.14	78.25
Days Outstanding Inventory (Average Inventory)	330.2	270.16	239.89	251.18	301.47
Average Days Payable Outstanding	96.4	222.11	177.37	61.4	79.33
Cash Conversion Cycle (Average Days)	338.73	135.95	147.99	268.93	300.39
Long Term Solvency
Total Debt/Equity	347.56	140.89	543.14	-	-107.76
Total Debt / Total Capital	77.66	58.49	84.45	100	1.39K
LT Debt/Equity	332.93	135.47	521.57	-	-99.71
Long-Term Debt / Total Capital	74.39	56.24	81.1	95.74	1.29K
Total Liabilities / Total Assets	94.64	88.92	97.12	100	126.38
EBIT / Interest Expense	5.18	10.39	9.64	8.67	7.07
EBITDA / Interest Expense	6.41	11.44	10.5	9.27	8
(EBITDA - Capex) / Interest Expense	6.18	11.22	10.27	9	7.29
Total Debt / EBITDA	2.61	1.39	1.2	1.01	1.14
Net Debt / EBITDA	-5.26	-3.96	-2.67	-0.46	0.17
Total Debt / (EBITDA - Capex)	2.71	1.42	1.23	1.04	1.25
Net Debt / (EBITDA - Capex)	-5.46	-4.04	-2.73	-0.47	0.18
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-17.58	22.26	13.91	21.31	8.69
Gross Profit, 1 Yr. Growth %	-13.95	19.64	11.75	22.24	8.6
EBITDA, 1 Yr. Growth %	-52.8	97.03	12.06	21.17	23.92
EBITA, 1 Yr. Growth %	-54.59	105.32	12.44	21.3	19.34
EBIT, 1 Yr. Growth %	-56.44	112.5	13.37	23.22	19.34
Earnings From Cont. Operations, 1 Yr. Growth %	-210.45	-238.51	-125.85	-103.77	-101.55
Net Income, 1 Yr. Growth %	-210.45	-238.51	-125.85	-103.77	-101.55
Normalized Net Income, 1 Yr. Growth %	-62.14	121.79	21.51	30.77	7.54
Diluted EPS Before Extra, 1 Yr. Growth %	-212.19	-233.7	-128.24	-102.62	-101.61
Accounts Receivable, 1 Yr. Growth %	-6.77	12.85	8.91	15.45	0
Inventory, 1 Yr. Growth %	27.4	2.15	20	24.56	31.85
Net Property, Plant and Equip., 1 Yr. Growth %	-3.74	-7.77	-10.53	37.65	12.1
Total Assets, 1 Yr. Growth %	-7.32	19.66	-3.44	10.46	-25.06
Tangible Book Value, 1 Yr. Growth %	-85.4	505	-115.7	1.15K	73.53
Common Equity, 1 Yr. Growth %	-60.77	147.56	-74.88	-100	82.2
Cash From Operations, 1 Yr. Growth %	-227.81	-282.9	-101.13	7.78K	-112
Capital Expenditures, 1 Yr. Growth %	-42.86	0	25	60	262.5
Levered Free Cash Flow, 1 Yr. Growth %	-160.71	-415.65	7.6	-117.96	-237.97
Unlevered Free Cash Flow, 1 Yr. Growth %	-150.49	-465.42	8.1	-111.98	-303.52
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-19.76	0.38	18.01	17.55	14.83
Gross Profit, 2 Yr. CAGR %	-20.45	1.46	15.63	16.87	15.35
EBITDA, 2 Yr. CAGR %	-45.58	-3.57	48.59	16.27	17.73
EBITA, 2 Yr. CAGR %	-47.03	-3.44	51.94	16.51	16.14
EBIT, 2 Yr. CAGR %	-48.52	-3.78	55.21	17.91	16.14
Earnings From Cont. Operations, 2 Yr. CAGR %	-26.64	23.69	-40.16	-90.12	-78.68
Net Income, 2 Yr. CAGR %	-26.64	23.69	-40.16	-90.12	-78.68
Normalized Net Income, 2 Yr. CAGR %	-50.47	-8.36	63.69	25.39	14.14
Diluted EPS Before Extra, 2 Yr. CAGR %	-26.12	22.47	-38.55	-91.39	-78.24
Accounts Receivable, 2 Yr. CAGR %	-18.43	2.57	10.86	12.14	7.45
Inventory, 2 Yr. CAGR %	9.19	14.08	10.72	22.26	24.96
Net Property, Plant and Equip., 2 Yr. CAGR %	34.43	-5.77	-9.16	10.98	27.88
Total Assets, 2 Yr. CAGR %	-0.52	5.31	7.49	3.28	-13.65
Tangible Book Value, 2 Yr. CAGR %	5.41	-6.02	-2.53	39.95	331.64
Common Equity, 2 Yr. CAGR %	11.46	-1.45	-21.14	-	161.22
Cash From Operations, 2 Yr. CAGR %	-20.19	52.9	-85.6	-5.54	200
Capital Expenditures, 2 Yr. CAGR %	-39.7	-24.41	11.8	41.42	140.83
Levered Free Cash Flow, 2 Yr. CAGR %	-20.97	38.43	84.29	-56.09	-33.67
Unlevered Free Cash Flow, 2 Yr. CAGR %	-29.39	35.83	98.75	-64.05	-29.88
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-16.04	-7.67	4.7	19.1	14.52
Gross Profit, 3 Yr. CAGR %	-17.52	-8.86	4.78	17.79	14.55
EBITDA, 3 Yr. CAGR %	-20.23	-16.43	1.38	38.62	16.67
EBITA, 3 Yr. CAGR %	-21.32	-16.79	1.58	40.73	14.54
EBIT, 3 Yr. CAGR %	-23.03	-17.42	1.62	43.49	15.75
Earnings From Cont. Operations, 3 Yr. CAGR %	36.65	-9.33	-26.6	-76.18	-78.63
Net Income, 3 Yr. CAGR %	36.65	-9.33	-26.6	-76.18	-78.63
Normalized Net Income, 3 Yr. CAGR %	-19.76	-18.37	0.48	51.64	16.14
Diluted EPS Before Extra, 3 Yr. CAGR %	36.16	-9.97	-24.9	-78.53	-77.61
Accounts Receivable, 3 Yr. CAGR %	-11.36	-9.11	4.64	12.37	7.93
Inventory, 3 Yr. CAGR %	21.38	6.79	16.02	15.15	23.28
Net Property, Plant and Equip., 3 Yr. CAGR %	24.02	18.56	-7.39	4.34	13.53
Total Assets, 3 Yr. CAGR %	1.97	5.8	2.31	8.47	-10.37
Tangible Book Value, 3 Yr. CAGR %	-59.22	88.73	-48.24	127.98	43.02
Common Equity, 3 Yr. CAGR %	-26.08	45.43	-37.51	-	19.68
Cash From Operations, 3 Yr. CAGR %	-13.19	5.22	-70.19	17.74	-53.28
Capital Expenditures, 3 Yr. CAGR %	-48.91	-28.62	-10.61	25.99	93.54
Levered Free Cash Flow, 3 Yr. CAGR %	13.95	25.39	27.28	-15.25	-22.54
Unlevered Free Cash Flow, 3 Yr. CAGR %	34.04	22.14	25.87	-22.13	-19.24
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-8.59	-5.65	-3.79	1.69	8.64
Gross Profit, 5 Yr. CAGR %	-9.56	-7.15	-5.58	0.68	9.12
EBITDA, 5 Yr. CAGR %	-24.4	-12.99	2.3	-4.63	8.11
EBITA, 5 Yr. CAGR %	-25.15	-13.43	2.37	-4.8	6.98
EBIT, 5 Yr. CAGR %	-25.25	-13.54	1.9	-4.77	7.5
Earnings From Cont. Operations, 5 Yr. CAGR %	-8.28	42.41	-1.79	-62.65	-56.87
Net Income, 5 Yr. CAGR %	-8.28	42.41	-1.79	-62.65	-56.87
Normalized Net Income, 5 Yr. CAGR %	-24.41	-12.43	6.72	-3.08	5.64
Diluted EPS Before Extra, 5 Yr. CAGR %	-8.21	40.9	-0.96	-64.8	-55.82
Accounts Receivable, 5 Yr. CAGR %	1.16	-0.29	-3.06	-1.14	5.76
Inventory, 5 Yr. CAGR %	14.14	18.3	17	12.73	19.51
Net Property, Plant and Equip., 5 Yr. CAGR %	26.34	28.61	9.5	15.47	5.37
Total Assets, 5 Yr. CAGR %	10.32	8.67	4.14	4.78	-4.4
Tangible Book Value, 5 Yr. CAGR %	-43.29	-20.37	-42.22	67.45	20.91
Common Equity, 5 Yr. CAGR %	-21.72	-7.2	-24.14	-	10.74
Cash From Operations, 5 Yr. CAGR %	-9.62	-2.81	-57.69	0.78	-24.93
Capital Expenditures, 5 Yr. CAGR %	-31.74	-27.52	-30.12	-6.17	32.88
Levered Free Cash Flow, 5 Yr. CAGR %	-20.18	-9.13	38.11	-17.59	-2.29
Unlevered Free Cash Flow, 5 Yr. CAGR %	-23.73	-9.67	56.91	-25.12	-0.57